Co-occurring Hepatitis C, substance use, and psychiatric illness: treatment issues and developing integrated models of care. - Wikidata - awgldk - TriplyDB

Co-occurring Hepatitis C, substance use, and psychiatric illness: treatment issues and developing integrated models of care.

Co-occurring Hepatitis C, substance use, and psychiatric illness: treatment issues and developing integrated models of care.

http://www.wikidata.org/entity/Q36272273

about

Promoting HCV treatment completion for prison inmates: New York State's hepatitis C continuity program Psychiatric and substance use disorders co-morbidities and hepatitis C: Diagnostic and treatment implications Tangible resources for preparing patients for antiviral therapy for chronic hepatitis C A randomized controlled trial of an integrated care intervention to increase eligibility for chronic hepatitis C treatment.Antiviral therapy completion and response rates among hepatitis C patients with and without schizophrenia.Context of clinical care: the case of hepatitis C in underserved communities--a report from the Primary Care Multiethnic Network (PRIME Net) Consortium.Outcomes from a large 10 year hepatitis C treatment programme in people who inject drugs: No effect of recent or former injecting drug use on treatment adherence or therapeutic response.High prevalence of alcohol use among hepatitis C virus antibody positive injection drug users in three US cities Treatment for hepatitis C virus genotype 1 infection in HIV-infected individuals on methadone maintenance therapy.Severity of psychiatric and physical problems is associated with lower quality of life in methadone patients in Indonesia.Characteristics and impact of methamphetamine use in patients with chronic hepatitis C Assessing candidacy for acute hepatitis C treatment among active young injection drug users: a case-series report Hepatitis infection in the treatment of opioid dependence and abuse.Barriers to receiving hepatitis C treatment for people who inject drugs: Myths and evidence The Relationship Between Drug Use, Drug-related Arrests, and Chronic Pain Among Adults on Probation.Hepatitis C treatment of patients with bipolar disorder: a case series Managing chronic hepatitis C in primary-care settings: more than antiviral therapy Psychiatric and substance use disorders among methadone maintenance patients with chronic hepatitis C infection: effects on eligibility for hepatitis C treatment.Behavioral interventions for HIV-positive and HCV-positive drug users.Chronic hepatitis C and antiviral treatment regimens: where can psychology contribute?The acceptability and feasibility of peer worker support role in community based HCV treatment for injecting drug users.Psychiatric behavioral aspects of comanagement of hepatitis C virus and HIV Psychiatric management of the hepatitis C patient.An integrated alcohol abuse and medical treatment model for patients with hepatitis C Time to rethink antiviral treatment for hepatitis C in patients with coexisting mental health/substance abuse issues.Structural barriers in the context of opiate substitution treatment in Germany--a survey among physicians in primary care Critical issues in the treatment of hepatitis C virus infection in methadone maintenance patients.Evaluation of oral cannabinoid-containing medications for the management of interferon and ribavirin-induced anorexia, nausea and weight loss in patients treated for chronic hepatitis C virus.Exploring drug users' attitudes and decisions regarding hepatitis C (HCV) treatment in the U.S.Treatment options for patients with hepatitis C: role of pharmacists in optimizing treatment response and managing adverse events.Academic health center management of chronic diseases through knowledge networks: Project ECHO.Interferon-based hepatitis C treatment in patients with pre-existing severe mental illness and substance use disorders.Psychiatric management of HIV/HCV-coinfected patients beginning treatment for hepatitis C virus infection: survey of provider practices.Hepatitis C, mental health and equity of access to antiviral therapy: a systematic narrative review.Characteristics and TB treatment outcomes in TB patients with viral hepatitis, New York City, 2000-2010.Pain and opioid use in chronic liver disease: optimal treatment must address the mental health care needs of the patient.Hepatitis C services and individuals with serious mental illness.The role of hepatology nurse in the difficult-to-treat hepatitis C population.Eligibility for treatment of hepatitis C virus infection among young injection drug users in 3 US cities.From the bedside to the community: comparative effectiveness, health services, and implementation research.

P2860

Q24676385-E10B4EE2-3CF5-4852-8A92-1CB30E75D420 Q26798477-99E2AE57-6949-4001-8715-14725E20DC01 Q26858962-A2870A1E-47E7-4ACF-8971-0B01D53D42F0 Q30540697-5B0406FC-7D63-4503-8C8F-6034A003D824 Q33566074-FE7D4082-970C-48C2-8ED0-6EAB3B2D9EE5 Q33591192-C48ECC67-A64A-4096-B6BE-9EF4AEABD511 Q33821728-4E64AD70-DD03-41A3-B141-88DFFA8FBCBB Q33989662-258AC52A-2BAD-428E-B37C-BB024A371307 Q34417838-2009BCBC-FC28-40A8-A07D-C015F1DAEB67 Q34953130-6D07A306-6D10-4209-803A-1404C35F38A4 Q35116890-50197DD8-F3DF-4E08-BEEA-0AE8D4D2DFC0 Q35118973-FD7735CB-0E43-4DF7-87DA-991472A2B028 Q35389163-59D7091A-E003-4727-913A-60EE2F4CE87F Q35540200-EC56A09D-EAD7-45E9-89FD-242F4209496D Q35553915-4A6880B9-2ED6-4BCB-AA61-00929545C9CF Q35574487-82441588-BFC7-4290-8EC7-246C2D46037A Q35696990-42FA5147-F097-4E2C-B706-8BCF9E62DF39 Q36296243-2CAC774D-8089-4D56-86D7-F423D558EAD2 Q36389354-20AF3D47-8C54-4532-A7E9-6ABD1A1B21BF Q36418455-2A33C5FF-53E1-4981-8285-281F2DA5BEEE Q36535234-CBB8AB0C-8741-46D8-934C-2AD2FB4D6FF6 Q36619816-F5DC0320-D345-43AA-9FB4-AF4EA03450C2 Q36642912-9F69BC69-02ED-4CC8-BD64-C5FF4378C950 Q36651500-8DBEB8D1-257C-49A2-89C9-AC9476C450C8 Q36933104-74828F04-3FC1-46B8-B010-883787CC04C0 Q37046304-1C35D01F-9926-4AA5-945A-05C379C0A7F7 Q37142229-49E6662E-174D-428A-92C5-F689B775B2DE Q37144253-1B593A7C-C7CC-4A54-909D-B429D2F3F98E Q37232639-ECA65144-6A89-47AB-B94F-F1110C4E5352 Q37254462-583AC755-B9D2-404E-AFF8-41143E679B70 Q37374058-06CF120F-6392-4142-8188-F2B97F82F76B Q37432112-409F08D1-BCFD-4CD7-82D6-4EC4C15C12D0 Q37460279-ACC750F0-60AA-4A3D-8F15-0F42E591F065 Q38163604-5BA2B70C-3C01-4F85-8A18-92D4BC282130 Q41667609-686997CD-11E4-47AF-882E-B6983BEE48DF Q42580192-EDD7B440-2089-4CA5-BFDF-D061160CC22C Q42978310-50032E79-C224-4FC6-B830-6259799FE975 Q43159898-5B4D65BD-0524-41AF-AFD0-8340FBF47DB9 Q45420303-F1E6C877-2F51-464B-A2C1-AC527558F3D9 Q46608568-AF4E57EF-D2E1-4211-A549-D5FD3D8F844D

P2860

Co-occurring Hepatitis C, substance use, and psychiatric illness: treatment issues and developing integrated models of care.

http://www.wikidata.org/entity/Q36272273

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

2004年學術文章

@zh

2004年學術文章

@zh-hant

name

Co-occurring Hepatitis C, subs ...... ing integrated models of care.

@ast

Co-occurring Hepatitis C, subs ...... ing integrated models of care.

@en

type

label

Co-occurring Hepatitis C, subs ...... ing integrated models of care.

@ast

Co-occurring Hepatitis C, subs ...... ing integrated models of care.

@en

prefLabel

Co-occurring Hepatitis C, subs ...... ing integrated models of care.

@ast

Co-occurring Hepatitis C, subs ...... ing integrated models of care.

@en

P1433

Q36272273-1771F335-85CF-439E-B1E2-1AC215AAC9BF

P1476

Q36272273-A90030AB-0AE4-4784-B8FC-78E53FA5928B

P2093

Q36272273-0BCE1FF5-C363-45BD-86F4-259A588E8C6B

Q36272273-3EA0B888-0370-4ED3-ADBF-CEFA2BFBE005

Q36272273-5755E556-97F7-48AC-9283-55B780776832

Q36272273-5DA3A043-F99A-4292-AFDD-4D09251DFC9F

Q36272273-7925BE40-D264-4D8A-8FE4-7A6446B40FFA

Q36272273-8974E52F-1CC2-44F8-BFF5-67088B725E81

Q36272273-9C9294E6-3142-44C0-B413-E62E942F8D67

Q36272273-AFD8E285-8101-4676-9997-A0310384629C

Q36272273-D65AFF85-3A5D-4C97-8F1C-2B8073DC97D6

P2860

Q36272273-04CC247D-8459-4A93-B8ED-4C6FB2A07B12

Q36272273-06D65BB6-DB70-488B-8097-EFC611762E42

Q36272273-0B0CA23D-0A94-4AD5-B3BD-131309775B35

Q36272273-0CC4F8D6-E532-40FB-9024-1F8E09AD7224

Q36272273-0DB88D5F-4CBB-46BE-A925-D9908BA70743

Q36272273-0DF73D78-B003-4A1B-91A2-BE2686318036

Q36272273-0E6E87FA-CCEA-40E6-9384-A8F5184CEBBB

Q36272273-163EDE8E-976E-4321-905F-0C54CE8DA0AF

Q36272273-19060BD7-1660-4A64-9C81-410816EABD18

Q36272273-1A41D158-8EF9-4FA9-A5BF-0007998BFCFD

P2888

Q36272273-E81D1173-52A4-4109-AD30-00A09D592579

P304

Q36272273-9A4B29ED-0483-4AF8-A075-9D222854FFEE

P31

Q36272273-9F9F3CA6-2BB6-430A-A95B-80632FB178BD

P356

Q36272273-CCF122F3-3906-4368-81EE-3F538491DAD4

P433

Q36272273-4B192F12-131F-45D8-8771-3A32993720DA

P478

Q36272273-E201A2C4-C646-40F3-8B77-0C4240581D3A

P577

Q36272273-F9985FEA-446D-49F5-B50F-A6228263510B

P5875

Q36272273-04EF526E-A213-4E51-BCBC-E20876BA377B

P6179

Q36272273-27686650-E517-4CEF-BB0A-B1AA2D0ED89A

P698

Q36272273-314415C4-EDE3-4EC4-96E1-F902768F56B2

P921

Q36272273-C444BBAE-98B7-492B-A98B-9E3AF02954AA

P932

Q36272273-5FAD739D-F800-48CD-9F76-C5D686929D33

P356

P1433

Journal of Urban Health

P1476

Co-occurring Hepatitis C, subs ...... ing integrated models of care.

@en

P2093

Diana L Sylvestre

http://www.w3.org/2001/XMLSchema#string

Helen Cesari

http://www.w3.org/2001/XMLSchema#string

Henry Francis

http://www.w3.org/2001/XMLSchema#string

Jennifer M Loftis

http://www.w3.org/2001/XMLSchema#string

Leonard Seeff

http://www.w3.org/2001/XMLSchema#string

Nicolette Borek

http://www.w3.org/2001/XMLSchema#string

Peter Hauser

http://www.w3.org/2001/XMLSchema#string

Sander Genser

http://www.w3.org/2001/XMLSchema#string

Thomas F Kresina

http://www.w3.org/2001/XMLSchema#string

P2860

An Inventory for Measuring Depression

Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation

Screening for alcohol problems in primary care: a systematic review

The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Ambulatory Care Quality Improvement Project (ACQUIP). Alcohol Use Disorders Identification Test

Cellular and molecular mechanisms of drug dependence

The Alcohol Use Disorders Identification Test (AUDIT): validation of a screening instrument for use in medical settings

The neural basis of drug craving: an incentive-sensitization theory of addiction

A rating scale for mania: reliability, validity and sensitivity

Treatment for amphetamine psychosis.

Cerebral dysfunction in chronic hepatitis C infection.

P2888

P304

719-734

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/JURBAN/JTH153

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

81

http://www.w3.org/2001/XMLSchema#string

P577

2004-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8248520

http://www.w3.org/2001/XMLSchema#string

P6179

1022952904

http://www.w3.org/2001/XMLSchema#string

P698

15466851

http://www.w3.org/2001/XMLSchema#string

P921

P932

3455918

http://www.w3.org/2001/XMLSchema#string